A unique aspect of Beech Tree Labs (BTL) that distinguishes it from biotech start-ups is the amount of technology, and the corresponding number of indications, it owns. This level of proven capability is the result of the efforts of its founder and president, John McMichael, Ph.D., and the network of practicing physicians, medical scientists, and business people he has developed over decades of investigating Resonant Molecular...
A unique aspect of Beech Tree Labs (BTL) that distinguishes it from biotech start-ups is the amount of technology, and the corresponding number of indications, it owns. This level of proven capability is the result of the efforts of its founder and president, John McMichael, Ph.D., and the network of practicing physicians, medical scientists, and business people he has developed over decades of investigating Resonant Molecular Signaling therapies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.